| Jenny Khan, FNP-C | |
|
1400 S Loop 336 W, Conroe, TX 77304-3317 | |
| (936) 523-5150 | |
| Not Available |
| Full Name | Jenny Khan |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 12 Years |
| Location | 1400 S Loop 336 W, Conroe, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063833754 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LC1500X | Nurse Practitioner - Community Health | 731144 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Harris Health System | Houston, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baylor College Of Medicine | 8224941265 | 684 |
News Archive
In experiments with mice, a research team led by Johns Hopkins scientists has discovered an unusual protein pair that stops blood vessels' growth in the developing back.
A gentle nudge in the right direction is sometimes all people need. In this case, new research in the INFORMS journal Marketing Science finds it works when it comes to promoting healthy eating.
Kane Biotech Inc., a biotechnology company engaged in the development of products that prevent and remove microbial biofilms is pleased to announce that DispersinB® Topical Wound Gel has passed the FDA-recommended Cytotoxicity and Primary Skin Irritation tests conducted by WuXi AppTec Inc. (St. Paul, MN) in compliance with Good Laboratory Practice (GLP). Thus, DispersinB® wound gel is considered non-cytotoxic and non-irritant.
Former Vice President Joe Biden has said if he's elected president he would build on the Affordable Care Act rather than move to a whole new health care system, such as the "Medicare for All" plan supported by some of his primary opponents for the Democratic nomination.
› Verified 7 days ago
| Entity Name | Baylor College Of Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053352914 PECOS PAC ID: 8224941265 Enrollment ID: O20031106000562 |
News Archive
In experiments with mice, a research team led by Johns Hopkins scientists has discovered an unusual protein pair that stops blood vessels' growth in the developing back.
A gentle nudge in the right direction is sometimes all people need. In this case, new research in the INFORMS journal Marketing Science finds it works when it comes to promoting healthy eating.
Kane Biotech Inc., a biotechnology company engaged in the development of products that prevent and remove microbial biofilms is pleased to announce that DispersinB® Topical Wound Gel has passed the FDA-recommended Cytotoxicity and Primary Skin Irritation tests conducted by WuXi AppTec Inc. (St. Paul, MN) in compliance with Good Laboratory Practice (GLP). Thus, DispersinB® wound gel is considered non-cytotoxic and non-irritant.
Former Vice President Joe Biden has said if he's elected president he would build on the Affordable Care Act rather than move to a whole new health care system, such as the "Medicare for All" plan supported by some of his primary opponents for the Democratic nomination.
› Verified 7 days ago
| Entity Name | Texas Em-i Medical Services, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457428849 PECOS PAC ID: 6507760543 Enrollment ID: O20031201000296 |
News Archive
In experiments with mice, a research team led by Johns Hopkins scientists has discovered an unusual protein pair that stops blood vessels' growth in the developing back.
A gentle nudge in the right direction is sometimes all people need. In this case, new research in the INFORMS journal Marketing Science finds it works when it comes to promoting healthy eating.
Kane Biotech Inc., a biotechnology company engaged in the development of products that prevent and remove microbial biofilms is pleased to announce that DispersinB® Topical Wound Gel has passed the FDA-recommended Cytotoxicity and Primary Skin Irritation tests conducted by WuXi AppTec Inc. (St. Paul, MN) in compliance with Good Laboratory Practice (GLP). Thus, DispersinB® wound gel is considered non-cytotoxic and non-irritant.
Former Vice President Joe Biden has said if he's elected president he would build on the Affordable Care Act rather than move to a whole new health care system, such as the "Medicare for All" plan supported by some of his primary opponents for the Democratic nomination.
› Verified 7 days ago
| Entity Name | Native Urban Healthcare Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053913723 PECOS PAC ID: 3678980034 Enrollment ID: O20210408001052 |
News Archive
In experiments with mice, a research team led by Johns Hopkins scientists has discovered an unusual protein pair that stops blood vessels' growth in the developing back.
A gentle nudge in the right direction is sometimes all people need. In this case, new research in the INFORMS journal Marketing Science finds it works when it comes to promoting healthy eating.
Kane Biotech Inc., a biotechnology company engaged in the development of products that prevent and remove microbial biofilms is pleased to announce that DispersinB® Topical Wound Gel has passed the FDA-recommended Cytotoxicity and Primary Skin Irritation tests conducted by WuXi AppTec Inc. (St. Paul, MN) in compliance with Good Laboratory Practice (GLP). Thus, DispersinB® wound gel is considered non-cytotoxic and non-irritant.
Former Vice President Joe Biden has said if he's elected president he would build on the Affordable Care Act rather than move to a whole new health care system, such as the "Medicare for All" plan supported by some of his primary opponents for the Democratic nomination.
› Verified 7 days ago
| Entity Name | Memorial Hermann Urgent Care Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730821208 PECOS PAC ID: 4880071679 Enrollment ID: O20220517001605 |
News Archive
In experiments with mice, a research team led by Johns Hopkins scientists has discovered an unusual protein pair that stops blood vessels' growth in the developing back.
A gentle nudge in the right direction is sometimes all people need. In this case, new research in the INFORMS journal Marketing Science finds it works when it comes to promoting healthy eating.
Kane Biotech Inc., a biotechnology company engaged in the development of products that prevent and remove microbial biofilms is pleased to announce that DispersinB® Topical Wound Gel has passed the FDA-recommended Cytotoxicity and Primary Skin Irritation tests conducted by WuXi AppTec Inc. (St. Paul, MN) in compliance with Good Laboratory Practice (GLP). Thus, DispersinB® wound gel is considered non-cytotoxic and non-irritant.
Former Vice President Joe Biden has said if he's elected president he would build on the Affordable Care Act rather than move to a whole new health care system, such as the "Medicare for All" plan supported by some of his primary opponents for the Democratic nomination.
› Verified 7 days ago
| Entity Name | Native Healthcare Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053913723 PECOS PAC ID: 6305211251 Enrollment ID: O20230407000822 |
News Archive
In experiments with mice, a research team led by Johns Hopkins scientists has discovered an unusual protein pair that stops blood vessels' growth in the developing back.
A gentle nudge in the right direction is sometimes all people need. In this case, new research in the INFORMS journal Marketing Science finds it works when it comes to promoting healthy eating.
Kane Biotech Inc., a biotechnology company engaged in the development of products that prevent and remove microbial biofilms is pleased to announce that DispersinB® Topical Wound Gel has passed the FDA-recommended Cytotoxicity and Primary Skin Irritation tests conducted by WuXi AppTec Inc. (St. Paul, MN) in compliance with Good Laboratory Practice (GLP). Thus, DispersinB® wound gel is considered non-cytotoxic and non-irritant.
Former Vice President Joe Biden has said if he's elected president he would build on the Affordable Care Act rather than move to a whole new health care system, such as the "Medicare for All" plan supported by some of his primary opponents for the Democratic nomination.
› Verified 7 days ago
| Entity Name | Emergency Medicine Services Of Tx Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245938729 PECOS PAC ID: 3375909351 Enrollment ID: O20230517001124 |
News Archive
In experiments with mice, a research team led by Johns Hopkins scientists has discovered an unusual protein pair that stops blood vessels' growth in the developing back.
A gentle nudge in the right direction is sometimes all people need. In this case, new research in the INFORMS journal Marketing Science finds it works when it comes to promoting healthy eating.
Kane Biotech Inc., a biotechnology company engaged in the development of products that prevent and remove microbial biofilms is pleased to announce that DispersinB® Topical Wound Gel has passed the FDA-recommended Cytotoxicity and Primary Skin Irritation tests conducted by WuXi AppTec Inc. (St. Paul, MN) in compliance with Good Laboratory Practice (GLP). Thus, DispersinB® wound gel is considered non-cytotoxic and non-irritant.
Former Vice President Joe Biden has said if he's elected president he would build on the Affordable Care Act rather than move to a whole new health care system, such as the "Medicare for All" plan supported by some of his primary opponents for the Democratic nomination.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jenny Khan, FNP-C Po Box 680608, Houston, TX 77268-0608 Ph: () - | Jenny Khan, FNP-C 1400 S Loop 336 W, Conroe, TX 77304-3317 Ph: (936) 523-5150 |
News Archive
In experiments with mice, a research team led by Johns Hopkins scientists has discovered an unusual protein pair that stops blood vessels' growth in the developing back.
A gentle nudge in the right direction is sometimes all people need. In this case, new research in the INFORMS journal Marketing Science finds it works when it comes to promoting healthy eating.
Kane Biotech Inc., a biotechnology company engaged in the development of products that prevent and remove microbial biofilms is pleased to announce that DispersinB® Topical Wound Gel has passed the FDA-recommended Cytotoxicity and Primary Skin Irritation tests conducted by WuXi AppTec Inc. (St. Paul, MN) in compliance with Good Laboratory Practice (GLP). Thus, DispersinB® wound gel is considered non-cytotoxic and non-irritant.
Former Vice President Joe Biden has said if he's elected president he would build on the Affordable Care Act rather than move to a whole new health care system, such as the "Medicare for All" plan supported by some of his primary opponents for the Democratic nomination.
› Verified 7 days ago
Ashley Mcgrath, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 122 Deerfield Meadow Dr, Conroe, TX 77384 Phone: 281-935-9718 | |
Poonam Gupta, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 4714 Fm 1488 Rd Ste 132, Conroe, TX 77384 Phone: 877-868-2528 | |
Jasmine Williams, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3600 Fm 1488 Rd, Conroe, TX 77384 Phone: 832-447-1367 | |
Esele Uwagwe, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 9297 Wahrenberger Rd, Conroe, TX 77304 Phone: 936-788-7770 | |
Ashley Cox, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 800 Riverwood Ct Ste 105, Conroe, TX 77304 Phone: 936-760-4454 Fax: 936-760-4415 | |
Danielle Lee Nielsen, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1560 League Line Rd Apt 2205, Conroe, TX 77304 Phone: 936-525-0786 | |
Carolina Deandres, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 503 Medical Center Blvd Ste 100, Conroe, TX 77304 Phone: 936-788-1030 Fax: 936-788-2844 |